Fabrizio Manetti

发表

Novel Virtual Screening Protocol Based on the Combined Use of Molecular Modeling and Electron-Ion Interaction Potential Techniques To Design HIV-1 Integrase Inhibitors

Cristina Tintori, Fabrizio Manetti, Nevena Veljkovic, 2007, J. Chem. Inf. Model..

Research on anti-HIV-1 agents. Investigation on the CD4-Suradista binding mode through docking experiments

Fabrizio Manetti, Maurizio Botta, Federico Corelli, 2000, J. Comput. Aided Mol. Des..

Toward a generalized computational workflow for exploiting transient pockets as new targets for small molecule stabilizers: Application to the homogentisate 1, 2-dioxygenase mutants at the base of rare disease Alkaptonuria

Fabrizio Manetti, Andrea Bernini, Ottavia Spiga, 2017, Comput. Biol. Chem..

Molecular Dynamics and DFT Study on HIV-1 Nucleocapsid Protein-7 in Complex with Viral Genome

Fabrizio Manetti, Maurizio Botta, Mattia Mori, 2010, J. Chem. Inf. Model..

A Genetic-Function-Approximation-Based QSAR Model for the Affinity of Arylpiperazines toward alpha1 Adrenoceptors

Fabrizio Manetti, Maurizio Botta, Matteo Magnani, 2006, J. Chem. Inf. Model..

In Memory of Maurizio Botta: His Contribution to the Development of Computer-Aided Drug Design

Fabrizio Manetti, Mattia Mori, Andrea Tafi, 2019, J. Chem. Inf. Model..

Developing Pyrrole‐Derived Antimycobacterial Agents: a Rational Lead Optimization Approach

Fabrizio Manetti, Maurizio Botta, Mariangela Biava, 2011, ChemMedChem.

Targets Looking for Drugs: A Multistep Computational Protocol for the Development of Structure-Based Pharmacophores and Their Applications for Hit Discovery

Cristina Tintori, Fabrizio Manetti, Maurizio Botta, 2008, J. Chem. Inf. Model..

A Combination of Molecular Dynamics and Docking Calculations to Explore the Binding Mode of ADS-J1, a Polyanionic Compound Endowed with Anti-HIV-1 Activity

Cristina Tintori, Fabrizio Manetti, Silvio Massa, 2006, J. Chem. Inf. Model..

Pharmacophore-Based Virtual Screening for Identification of Negative Modulators of GLI1 as Potential Anticancer Agents.

Fabrizio Manetti, Barbara Stecca, Roberta Santini, 2020, ACS medicinal chemistry letters.

Construction and Validation of a RET TK Catalytic Domain by Homology Modeling

Fabrizio Manetti, Maurizio Botta, Tiziano Tuccinardi, 2007, J. Chem. Inf. Model..

Predicting the Binding Mode of Known NCp7 Inhibitors To Facilitate the Design of Novel Modulators

Fabrizio Manetti, Maurizio Botta, Mattia Mori, 2011, J. Chem. Inf. Model..

A combination of docking/dynamics simulations and pharmacophoric modeling to discover new dual c-Src/Abl kinase inhibitors.

Fabrizio Manetti, Maurizio Botta, Stefano Forli, 2006, Journal of medicinal chemistry.

Antimycobacterial agents. Novel diarylpyrrole derivatives of BM212 endowed with high activity toward Mycobacterium tuberculosis and low cytotoxicity.

Fabrizio Manetti, Maurizio Botta, Paola Molicotti, 2006, Journal of medicinal chemistry.

Identification of a novel pyrrole derivative endowed with antimycobacterial activity and protection index comparable to that of the current antitubercular drugs streptomycin and rifampin.

Fabrizio Manetti, Maurizio Botta, Claudio Battilocchio, 2010, Bioorganic & medicinal chemistry.

Molecular basis for the binding of competitive inhibitors of maize polyamine oxidase.

Fabrizio Manetti, Maurizio Botta, Fabio Polticelli, 2004, Biochemistry.

1,5-Diphenylpyrrole derivatives as antimycobacterial agents. Probing the influence on antimycobacterial activity of lipophilic substituents at the phenyl rings.

Fabrizio Manetti, Maurizio Botta, Mariangela Biava, 2008, Journal of medicinal chemistry.

Design and Synthesis of Thiadiazoles and Thiazoles Targeting the Bcr‐Abl T315I Mutant: from Docking False Positives to ATP‐Noncompetitive Inhibitors

Fabrizio Manetti, Maurizio Botta, Marco Radi, 2010, ChemMedChem.

Application of Pharmacophore Models in Medicinal Chemistry

Fabrizio Manetti, Maurizio Botta, Andrea Tafi, 2006 .

N-(thiazol-2-yl)-2-thiophene carboxamide derivatives as Abl inhibitors identified by a pharmacophore-based database screening of commercially available compounds.

Fabrizio Manetti, Maurizio Botta, Silvia Schenone, 2008, Bioorganic & medicinal chemistry letters.

HIV-reverse transcriptase inhibition: inclusion of ligand-induced fit by cross-docking studies.

Fabrizio Manetti, Silvio Massa, Rino Ragno, 2005, Journal of medicinal chemistry.

Small Molecule Inhibitors Targeting HIV‐1 Reverse Transcriptase Dimerization

Fabrizio Manetti, Maurizio Botta, Valentina Corradi, 2008, Chembiochem : a European journal of chemical biology.

1,5-Diaryl-2-ethyl pyrrole derivatives as antimycobacterial agents: design, synthesis, and microbiological evaluation.

Fabrizio Manetti, Maurizio Botta, Mariangela Biava, 2009, European journal of medicinal chemistry.

Computational techniques are valuable tools for the discovery of protein-protein interaction inhibitors: the 14-3-3σ case.

Fabrizio Manetti, Maurizio Botta, Valentina Corradi, 2011, Bioorganic & medicinal chemistry letters.

Indolyl-pyrrolone as a new scaffold for Pim1 inhibitors.

Fabrizio Manetti, Maurizio Botta, Silvia Schenone, 2009, Bioorganic & medicinal chemistry letters.

3D QSAR Models Built on Structure‐Based Alignments of Abl Tyrosine Kinase Inhibitors

Fabrizio Manetti, Maurizio Botta, Silvia Schenone, 2009, ChemMedChem.

Synthetic SRC-kinase domain inhibitors and their structural requirements.

Fabrizio Manetti, Maurizio Botta, Silvia Schenone, 2007, Anti-cancer agents in medicinal chemistry.

Identification of the first non-peptidic small molecule inhibitor of the c-Abl/14-3-3 protein-protein interactions able to drive sensitive and Imatinib-resistant leukemia cells to apoptosis.

Fabrizio Manetti, Maurizio Botta, Valentina Corradi, 2010, Bioorganic & medicinal chemistry letters.